David McDermott is an Oncology physician affiliated with Beth Israel Deaconess Medical Center. ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Boston, MA 022155400
Telephone
617-667-1930Registry record last updated 8 Jul 2007.
Clinical trials
- Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
Sponsor: Beth Israel Deaconess Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20251 payment
- PFIZER INC.Program year20252 payments
- Exelixis Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
FY2026$424,605R01CA258442 - DF/HCC Kidney Cancer SPORE (supplement)
Beth Israel Deaconess Medical Center
FY2025$1,230,080P50CA101942 - Developing a Translation Pipeline for VHL Mutant Malignancies
Beth Israel Deaconess Medical Center
FY2025$606,369U01CA236489
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”